Compare Oxford Lane Capital Corp (OXLC) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oxford Lane Capital Corp vs Relay Therapeutics Inc. Common Stock — how do they compare? Oxford Lane Capital Corp trades at $8.62 (market cap $829.34M), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 4.8× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 28.37% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oxford Lane Capital Corp for 49 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| OXLC | RLAY | |
|---|---|---|
Market Cap | $829.34M | $3.94B |
Volume | 1,709,917 | 3,432,928 |
Sector | Financials | Health |
52-Week High | $16.74 | $20.75 |
52-Week Low | $8.15 | $6.03 |
Typical Hold Time | 49 Days | 0 Days |
Enterprise Value | $1.22B | $3.06B |
Dividend Yield | 28.37% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OXLC trades at $8.46, down 2.53% on the day, with a bearish technical outlook and negative profitability metrics. Recent earnings misses and a sharp decline in net income for 2026 highlight fundamental challenges, though the stock pays consistent dividends. Analyst sentiment is mixed, with a 50% buy rating but cautious media coverage on sustainability.
The outlook remains risky due to volatile earnings, high payout ratios, and NAV erosion. Potential exists for value investors attracted by the P/B discount and high yield, but significant headwinds in CLO market exposure and operational cash flow deficits warrant caution for near-term performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
